News About: Pharm. Industry
Multinational drug giants go for dual in Korean pharmaceutical market
This year, competition is about to heat up in the Korean pharmaceutical market as a growing number of new products would be launched by foreign drug makers.
GSK is about to set foot in the market with its newly dev...
Green Cross names new president
Green Cross Corporation has appointed Hur Jae-hoi as its new president.
A graduate of Yonsei University having a bachelor degree of biochemistry, Hur has held a variety of positions at Green Cross after joining the...
Yuyu filed patent lawsuit for Maxmarvil against MSD.
Yuyu filed a lawsuit against Merck company of America to identify the scope of patent claims for Maxmarvil (alendronate sodium plus calcitriol), which attracts a keen interest to the drug industry in viewing that the ...
48% of drugs being produced at less than 100 million won.
48% of the total drugs in Korea were produced at a value of less than 100 million won a year, implying a necessity for massive product transformations.
The KPMA report revealed that the total 16,061 products were p...
Pharmaceutical stocks to power in Korean Exchange this year
Despite a variety of adverse factors, securities firms hold a rosy outlook for domestic pharmaceutical industry in 2007.
Analysts pick the leading pharmaceutical firms Hanmi Pharm, Dong-A Pharm, Chong Kun Dang, Da...
National health insurance covers BaracludeThe Ministry of Health Welfare said on January 1 that the national health insurance has covered BMS Korea's Baraclude (entecavir). Baraclude 0.5 mg, 1mg tablets are priced at 7,...
|
Top executive organization of Janssen Korea reshuffled.President Park Jae-wha of Janssen Korea, an affiliate of Johnson and Johnson was promoted to the chief executive officer of Hong Kang and Taiwan operation as of Jan. 2, 2007 and...
|
Korean drug makers to release 5 new medicines this year
Korean pharmaceutical firms will launch five new drugs on the domestic market this year following 12 new items, such as Zydena, according to the Korea Drug Research Association.
New medicines that are to be commer...
Korean biopharmaceutical firms join hands with foreign partners via technology transfer
Some Korean biopharmaceutical companies have teamed up with foreign partners in the biotechnology sector via technology tie-ups and joint research collaboration, according to the Korea Health Industry Development Indu...
SK Chemcals picks new vice chairman
SK Chemicals said on January 1 that it appointed Choi Chang-won, the current vice president of SK Chemicals as a new vice chairman. SK Chemicals also named four people as executive directors Lee Bong-yong, Oh Myung-w...
